{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:57:31Z","timestamp":1792036651939,"version":"4.4.0"},"reference-count":6,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T00:00:00Z","timestamp":1556236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,10]]},"DOI":"10.1093\/neuonc\/noz051","type":"journal-article","created":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T15:54:50Z","timestamp":1554998090000},"page":"822-824","source":"Crossref","is-referenced-by-count":16,"title":["Sustained imaging response and hearing preservation with low-dose bevacizumab in sporadic vestibular schwannoma"],"prefix":"10.1093","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7151-6528","authenticated-orcid":false,"given":"Matthias A","family":"Karajannis","sequence":"first","affiliation":[{"name":"Pediatric Neuro-Oncology Service, Department of Pediatrics, Memorial Sloan Kettering Cancer Center (MSKCC), New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Hagiwara","sequence":"additional","affiliation":[{"name":"Department of Radiology, NYU Langone Health, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schreyer","sequence":"additional","affiliation":[{"name":"Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Haque","sequence":"additional","affiliation":[{"name":"Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,4,26]]},"reference":[{"issue":"14","key":"2019061005404352400_CIT0001","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1200\/JCO.2015.64.3817","article-title":"Efficacy and biomarker study of bevacizumab for hearing loss resulting from neurofibromatosis type 2-associated vestibular schwannomas","volume":"34","author":"Blakeley","year":"2016","journal-title":"J Clin Oncol."},{"issue":"9","key":"2019061005404352400_CIT0002","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/neuonc\/nos146","article-title":"Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas","volume":"14","author":"Karajannis","year":"2012","journal-title":"Neuro Oncol."},{"issue":"1","key":"2019061005404352400_CIT0003","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11060-016-2276-9","article-title":"Toxicity profile of bevacizumab in the UK Neurofibromatosis type 2 cohort","volume":"131","author":"Morris","year":"2017","journal-title":"J Neurooncol."},{"issue":"2","key":"2019061005404352400_CIT0004","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/neuonc\/nov168","article-title":"Vascular biomarkers derived from dynamic contrast-enhanced MRI predict response of vestibular schwannoma to antiangiogenic therapy in type 2 neurofibromatosis","volume":"18","author":"Li","year":"2016","journal-title":"Neuro Oncol."},{"issue":"3","key":"2019061005404352400_CIT0005","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.otc.2015.02.003","article-title":"Management of sporadic vestibular schwannoma","volume":"48","author":"Carlson","year":"2015","journal-title":"Otolaryngol Clin North Am."},{"key":"2019061005404352400_CIT0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/2018.5.JNS18508","article-title":"Comparing costs of microsurgical resection and stereotactic radiosurgery for vestibular schwannoma","author":"Schnurman","year":"2018","journal-title":"J Neurosurg"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noz051\/28532188\/noz051.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/21\/6\/822\/28788901\/noz051.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T05:41:25Z","timestamp":1560145285000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/21\/6\/822\/5480279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,26]]},"references-count":6,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,4,26]]},"published-print":{"date-parts":[[2019,6,10]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noz051","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,6]]},"published":{"date-parts":[[2019,4,26]]}}}